Anubis Bio is a technology company.
Anubis Bio has raised $1.0M across 1 funding round.
Anubis Bio has raised $1.0M in total across 1 funding round.
Anubis Bio has raised $1.0M in total across 1 funding round.
Anubis Bio's investors include Human Augmentation Syndicate, NFX, Esther Dyson.
Anubis Bio is an animal health company developing natural food supplements to support and improve gastrointestinal health in pets.[1][2][5] It offers the first patented Microbiome-Cleanser (TM) for animal gut and immune support, targeting pet owners seeking natural solutions for digestive and intestinal wellness.[2][4] The company serves the pet health market, addressing issues like microbiome imbalances with products that enhance overall pet vitality, and has shown early momentum through its patented technology and operations in biotechnology research.[3][4]
Headquartered in locations including Orlando, FL, and associated with San Francisco, CA, Anubis Bio operates in the agriculture and pharmaceuticals space with modest funding around $196,000, focusing on non-drug, natural interventions amid rising demand for pet wellness products.[3][4]
Anubis Bio Corporation was founded in 2018, establishing itself as an animal health innovator.[4] While specific founders are not detailed in available sources, the company emerged from biotechnology research expertise, likely driven by the need for natural alternatives in pet care.[3] Early traction came from patenting its Microbiome-Cleanser (TM), a pioneering product for gut and immune support, positioning it quickly in the competitive animal health sector.[2] Headquartered initially in Orlando, FL, with ties to San Francisco's biotech ecosystem, it pivoted toward practical, supplement-based solutions for pet digestive health.[3][4]
Anubis Bio rides the wave of the booming pet tech and animal health sector, fueled by surging pet ownership and demand for microbiome-focused wellness products post-pandemic.[1][2] Its timing aligns with market forces like the rise of personalized pet nutrition and natural supplements, where consumers prioritize gut health amid growing awareness of animal microbiomes' role in immunity.[5] In the wider ecosystem, it contributes to biotech advancements in agriculture and veterinary care, influencing startups by validating natural, patented cleansers as viable alternatives to antibiotics, potentially expanding into larger agribusiness applications.[2][3]
Anubis Bio is poised for growth by scaling its patented Microbiome-Cleanser into broader pet product lines and possibly livestock applications, capitalizing on natural health trends.[2] Emerging trends like AI-driven pet diagnostics and sustainable biotech will shape its path, amplifying its influence in the $100B+ pet industry. As it builds on early funding and patents, expect partnerships with vets and retailers to evolve its role from niche innovator to key player in preventive animal health.[3][4] This positions Anubis Bio to lead natural gut support solutions, echoing its founding mission to enhance pet lives through science-backed supplements.
Anubis Bio has raised $1.0M across 1 funding round. Most recently, it raised $1.0M Seed in March 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 1, 2020 | $1.0M Seed | Human Augmentation Syndicate, NFX, Esther Dyson |